Spring til hovednavigation Spring til søgning Spring til hovedindhold

Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin

  • Håvard Jenssen*
  • , Kjersti Sandvik
  • , Jeanette H. Andersen
  • , Robert E. W. Hancock
  • , Tore J. Gutteberg
  • *Corresponding author

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

The milk protein lactoferrin (Lf) has multiple functions, including immune stimulation and antiviral activity towards herpes simplex virus 1 and 2 (HSV-1 and HSV-2); antiviral activity has also been reported for the N-terminal pepsin-derived fragment lactoferricin (Lfcin). The anti-HSV mode of action of Lf and Lfcin is assumed to involve, in part, their interaction with the cell surface glycosaminoglycan heparan sulfate, thereby blocking of viral entry. In this study we investigated the ability of human and bovine Lf and Lfcin to inhibit viral cell-to-cell spread as well as the involvement of cell surface glycosaminoglycans during viral cell-to-cell spread. Lf and Lfcin from both human and bovine origin, inhibited cell-to-cell spread of both HSV-1 and HSV-2. Inhibition of cell-to-cell spread by bovine Lfcin involved cell surface chondroitin sulfate. Based on transmission electron microscopy studies, human Lfcin, like bovine Lfcin, was randomly distributed intracellularly, thus differences in their antiviral activity could not be explained by differences in their distribution. In contrast, the cellular localization of iron-saturated (holo)-Lf appeared to differ from that of apo-Lf, indicating that holo- and apo-Lf may exhibit different antiviral mechanisms.
OriginalsprogEngelsk
TidsskriftAntiviral Research
Vol/bind79
Udgave nummer3
Sider (fra-til)192-198
ISSN0166-3542
DOI
StatusUdgivet - 2008
Udgivet eksterntJa

Citationsformater